Hakkımda
Klinik Araştırma Deneyimleri
| Görev | Çalışma / Protokol Adı | Tarih |
|---|---|---|
| SubI | Turkish Myeloma Study Group Thalidomid Multipmyelom Study | 2008-2011 |
| PI | Subkutan Rutiksimab Study | 2014-2016 |
| SubI | Relapse or Refractory DLBCL Study | 2013-2017 |
| SubI | Multipmyelom daramatumab Study | 2014-2018 |
| SubI | B32810006 | Folicular Lymphoma |
| SubI | RI-01-006 | Folicular Lymphoma |
| PI | Navitoclax- Ruxolitinib Combination | 2022-Halen |
| PI | Allovir( P105-202) | 2022-2024 |
| PI | Monitor (BV-ITP-BP) | 2023-2023 |
| PI | CSL964-2001 | 2023-2025 |
| PI | Abbvie M16-191 | 2022-2025 |